Intestinal Microbiota & UTI

Your gut is home to trillions of bacteria, which play an essential role in keeping your body healthy. However, when this balance is disrupted—a condition called gut dysbiosis—harmful bacteria like E. coli can overgrow, escape the gut, and cause UTIs. This article explores the growing evidence linking gut dysbiosis with urinary infections in men. By understanding this gut–bladder connection, we can explore new, natural ways to prevent recurring UTIs while reducing the overuse of antibiotics.

Understanding UTIs in Men

Symptoms can include a burning sensation while urinating, frequent urination (especially at night), pelvic or lower abdominal pain, cloudy or foul-smelling urine, and sometimes fever or chills. If left untreated, UTIs can spread to the kidneys, leading to more serious infections.

In men, UTIs are often associated with specific risk factors such as prostate enlargement, urinary catheter use, weakened immunity, diabetes, kidney stones, or poor personal hygiene. Infections can also occur more frequently in those with incomplete bladder emptying or a history of urethral procedures. Notably, 10–15% of men with lower urinary tract symptoms (LUTS) experience recurrent UTIs.

The most common cause of UTIs is Escherichia coli (E. coli)—a type of bacteria usually found in the gut. These bacteria can enter the urinary tract and trigger infection, particularly when the bladder’s natural defenses are weakened 

As men age, their risk for chronic or recurrent UTIs increases due to changes in urinary tract function and immune response. Understanding these risk factors is the first step toward prevention and effective treatment.

The Gut-Urinary Connection

Your gut is home to trillions of bacteria, collectively known as the intestinal microbiota. These microbes are essential for digesting food, producing nutrients, fighting harmful bacteria, and regulating the immune system. 

But when gut dysbiosis occurs, it can lead to more than just digestive problems. Studies now show that the gut may be a key player in the development of urinary tract infections (UTIs). Harmful bacteria like Escherichia coli (E. coli), which normally live harmlessly in the gut, can sometimes migrate to the bladder and cause infection. In fact, 80–90% of community-acquired UTIs are caused by these gut-derived E. coli strains.

Normally, friendly bacteria like Lactobacillus and Streptococcus in the urinary tract help defend against these invaders. However, antibiotics and gut imbalance can reduce these protective bacteria, making it easier for pathogens to take over.

Some strains of E. coli (called UPEC – uropathogenic E. coli) are particularly aggressive. They carry special tools—like adhesins and pili—that help them stick to the bladder lining and invade cells. Once inside, they form tiny biofilm communities, called intracellular bacterial communities (IBCs), which are shielded by a protective layer (uroplakin). This helps them hide from the immune system and survive longer.

They also produce LPS (lipopolysaccharide), a toxin that disrupts immune signaling and weakens the bladder lining. This allows them to go even deeper into the tissue and stay hidden, making infections harder to treat.

 Schematic representation of the mechanisms involved in urinary tract colonization (UPEC) 

Researchers have found the same strains of bacteria in both urine and stool samples of UTI patients, indicating a clear gut-to-bladder transmission path. People with recurrent UTIs often have reduced gut microbiome diversity, including lower levels of helpful bacteria that produce short-chain fatty acids (SCFAs)—natural compounds that protect the gut barrier and reduce inflammation.

Gut dysbiosis may not only increase the number of uropathogens but also weaken the body’s immune defenses, creating the perfect storm for infection. While more research is needed, there’s growing evidence that restoring gut balance may reduce UTI risk and improve urinary health in men.

How Correcting Gut Microbiota May Help 

Correcting the gut microbiota means restoring the balance of healthy bacteria in the intestines using probiotics, prebiotics, fiber-rich diets, or in some cases, fecal microbiota transplantation (FMT). These approaches aim to rebuild a diverse and stable microbial community that can protect the body from harmful pathogens, including those that cause urinary tract infections (UTIs).

Probiotics, especially strains like Lactobacillus rhamnosus GR-1, L. reuteri RC-14, and Bifidobacterium, are live microorganisms that promote healthy gut flora. These beneficial bacteria help crowd out harmful microbes like E. coli, enhance immune responses, reduce intestinal inflammation, and restore the gut barrier. Studies suggest that they can also positively influence the urinary tract by modifying local environments and preventing pathogen adhesion.

One study found that men with corrected gut microbiota had over a 30% reduction in recurrent UTIs. Other research has shown that even in difficult cases, like those with multidrug-resistant UTIs, FMT led to fewer infections and reduced hospitalizations.

Moreover, short-chain fatty acid (SCFA)-producing bacteria such as Faecalibacterium and Eubacterium hallii, which are often reduced in dysbiosis, play a key role in protecting both gut and urinary health. Increasing these through diet or supplements may help prevent infections naturally.

Although more research is needed, these microbiota-based strategies offer promising, non-antibiotic options to manage and reduce recurrent UTIs—especially in men with chronic infections.

Real-Life Example: Gut Imbalance and UTI Risk

John, a 67-year-old kidney transplant recipient, had been struggling with recurrent urinary tract infections (rUTIs) for over a year. Despite multiple antibiotic treatments, the infections kept coming back. His urologist, concerned about the frequent relapses and increasing resistance to antibiotics, recommended a stool analysis to investigate his gut health.

The test revealed gut dysbiosis—an imbalance in his intestinal microbiota—with a high abundance of uropathogenic E. coli strains. Studies support this gut–bladder link, showing that the gut acts as a reservoir for uropathogenic E. coli (UPEC), which can migrate to the urinary tract and trigger infections.

Under medical guidance, John began a tailored regimen including probiotic supplements (containing Lactobacillus and Bifidobacterium), increased dietary fiber, and reduced processed food intake. After three months, he reported feeling better and had no new UTIs.

This case underscores the importance of looking beyond the urinary tract when dealing with recurrent infections. A personalized gut-focused approach, guided by a healthcare provider, may help break the cycle of infection, especially in older men or those with complex medical histories like transplantation.

What You Can Do: Tips for Men to Improve Gut Health

Improving gut health can support the immune system, restore microbial balance, and potentially reduce the risk of recurrent urinary tract infections (UTIs). Here are key strategies men can follow:

• Eat more fiber

  Include fruits, vegetables, legumes, and whole grains in your diet. Fiber nourishes beneficial gut bacteria and promotes regular digestion.

• Avoid unnecessary antibiotics

  Use antibiotics only when prescribed. Overuse can lead to gut dysbiosis and may contribute to a cycle of recurring UTIs, as harmful bacteria like E. coli often persist in the gut even after treatment.

• Consider probiotics (with medical guidance)

  Specific strains like Lactobacillus rhamnosus GG and Bifidobacterium longum have shown potential in restoring gut balance and supporting urinary health. Ask your doctor before starting any probiotic supplement.

• Limit processed foods, alcohol, and sugar

  These can feed harmful bacteria and promote inflammation in the gut.

• Stay hydrated and physically active

  Drinking enough water and exercising regularly help maintain gut motility and overall microbiome health.

• Explore emerging microbiome therapies

  New approaches like fecal microbiota transplantation (FMT) have shown promise in reducing recurrent UTIs—especially in cases involving antibiotic-resistant bacteria. Probiotic therapies and research into phage therapy and anti-adhesion molecules also show potential.

When to See a Doctor ?

While some urinary symptoms may be mild, certain signs should never be ignored. Seek immediate medical attention if you experience:

• Fever
  

• Pain in the lower back or side (flank pain)
  

• Blood in the urine (hematuria)
  

These may indicate a kidney infection or more serious complications requiring urgent care.

Men with recurrent or chronic UTIs should go beyond standard antibiotic treatments and request a thorough evaluation for gut microbiota imbalances. Emerging research suggests that persistent gut dysbiosis may contribute to the recurrence of UTIs, even after appropriate antibiotic therapy.

Ask your healthcare provider about performing a stool test or microbiota assessment—especially in cases where infections return frequently or don’t respond well to treatment. This can guide personalized, non-antibiotic strategies, such as probiotic therapy or dietary interventions.

Conclusion

Recurrent UTIs in men are often complex and linked not only to urinary tract conditions but also to gut health. Growing research confirms that gut dysbiosis—an imbalance of intestinal bacteria—can fuel infections by allowing harmful microbes like E. coli to colonize the urinary tract. Correcting the gut microbiota through probiotics, fiber-rich diets, and personalized care offers a promising, non-antibiotic pathway to reduce infections and restore long-term health.

For added protection, especially for men managing incontinence or chronic UTIs, try QuickChange Wraps. We invite you to purchase a 10 Count Trial Pack here or request a professional-use sample pack for healthcare institutions here.

References:

1. Bonkat G, Cai T, Galeone C, Koves B, Bruyere F. Adherence to European Association of Urology Guidelines and State of the Art of Glycosaminoglycan Therapy for the Management of Urinary Tract Infections: A Narrative Review and Expert Meeting Report. Eur Urol Open Sci. 2022 Aug 23;44:37-45. doi: 10.1016/j.euros.2022.07.009. PMID: 36051173; PMCID: PMC9424561.

2. Brigida, M., Saviano, A., Petruzziello, C., Manetti, L. L., Migneco, A., & Ojetti, V. (2024). Gut Microbiome Implication and Modulation in the Management of Recurrent Urinary Tract Infection. Pathogens, 13(12), 1028. https://doi.org/10.3390/pathogens13121028

3. den Besten G, van Eunen K, Groen AK, Venema K, Reijngoud DJ, Bakker BM. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res. 2013 Sep;54(9):2325-40. doi: 10.1194/jlr.R036012. Epub 2013 Jul 2. PMID: 23821742; PMCID: PMC3735932.

4. Ejrnæs K. Bacterial characteristics of importance for recurrent urinary tract infections caused by Escherichia coli. Dan Med Bull. 2011 Apr;58(4):B4187. PMID: 21466767.

5. Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015 May;13(5):269-84. doi: 10.1038/nrmicro3432. Epub 2015 Apr 8. PMID: 25853778; PMCID: PMC4457377.

6. Iqbal ZS, Halkjær SI, Ghathian KSA, Heintz JE, Petersen AM. The Role of the Gut Microbiome in Urinary Tract Infections: A Narrative Review. Nutrients. 2024 Oct 24;16(21):3615. doi: 10.3390/nu16213615. PMID: 39519448; PMCID: PMC11547363.

7. Kurotschka PK, Gágyor I, Ebell MH. Acute Uncomplicated UTIs in Adults: Rapid Evidence Review. Am Fam Physician. 2024 Feb;109(2):167-174. PMID: 38393801.

8. Magruder M, Edusei E, Zhang L, Albakry S, Satlin MJ, Westblade LF, Malha L, Sze C, Lubetzky M, Dadhania DM, Lee JR. Gut commensal microbiota and decreased risk for Enterobacteriaceae bacteriuria and urinary tract infection. Gut Microbes. 2020 Nov 9;12(1):1805281. doi: 10.1080/19490976.2020.1805281. PMID: 32865119; PMCID: PMC7524266.

9. Magruder M, Sholi AN, Gong C, Zhang L, Edusei E, Huang J, Albakry S, Satlin MJ, Westblade LF, Crawford C, Dadhania DM, Lubetzky M, Taur Y, Littman E, Ling L, Burnham P, De Vlaminck I, Pamer E, Suthanthiran M, Lee JR. Gut uropathogen abundance is a risk factor for development of bacteriuria and urinary tract infection. Nat Commun. 2019 Dec 4;10(1):5521. doi: 10.1038/s41467-019-13467-w. PMID: 31797927; PMCID: PMC6893017.

10. Miquel S, Martín R, Rossi O, Bermúdez-Humarán LG, Chatel JM, Sokol H, Thomas M, Wells JM, Langella P. Faecalibacterium prausnitzii and human intestinal health. Curr Opin Microbiol. 2013 Jun;16(3):255-61. doi: 10.1016/j.mib.2013.06.003. Epub 2013 Jul 3. PMID: 23831042.

11. Worby CJ, Schreiber HL 4th, Straub TJ, van Dijk LR, Bronson RA, Olson BS, Pinkner JS, Obernuefemann CLP, Muñoz VL, Paharik AE, Azimzadeh PN, Walker BJ, Desjardins CA, Chou WC, Bergeron K, Chapman SB, Klim A, Manson AL, Hannan TJ, Hooton TM, Kau AL, Lai HH, Dodson KW, Hultgren SJ, Earl AM. Longitudinal multi-omics analyses link gut microbiome dysbiosis with recurrent urinary tract infections in women. Nat Microbiol. 2022 May;7(5):630-639. doi: 10.1038/s41564-022-01107-x. Epub 2022 May 2. PMID: 35505248; PMCID: PMC9136705.

12. Yamada CH, Ortis GB, Buso GM, Martins TC, Zequinao T, Telles JP, Wollmann LC, Montenegro CO, Dantas LR, Cruz JW, Tuon FF. Validation of Lyophilized Human Fecal Microbiota for the Treatment of Clostridioides difficile Infection: A Pilot Study with Pharmacoeconomic Analysis of a Middle-Income Country-Promicrobioma Project. Microorganisms. 2024 Aug 22;12(8):1741. doi: 10.3390/microorganisms12081741. PMID: 39203583; PMCID: PMC11356882.